deoxyglucose has been researched along with Granulocytic Leukemia, Chronic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, X; Liu, K; Liu, Q; Liu, Z; Ma, X; Meng, Q; Peng, J; Sun, H; Wang, C; Xue, C | 1 |
| Boros, LG; Brown, JL; Eckhardt, SG; Klawitter, J; Kominsky, DJ; Melo, JV; Serkova, NJ | 1 |
| Babendreier, E; Chauhan, D; Chu, SC; Gramlich, JL; Griffin, JD; Kim, JH; Podar, K; Pride, YB; Salgia, R; Sattler, M | 1 |
| Baldwin, SA; Barnes, K; Bentley, J; Daley, GQ; McIntosh, E; Whetton, AD | 1 |
| Baldwin, SA; Bentley, J; McIntosh, E; Owen-Lynch, PJ; Walker, I; Whetton, AD | 1 |
5 other study(ies) available for deoxyglucose and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin.
Topics: Antibiotics, Antineoplastic; Antimetabolites; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Proliferation; Deoxyglucose; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Therapy, Combination; Energy Metabolism; Humans; Hypoglycemic Agents; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Metformin; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2016 |
Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells.
Topics: Antineoplastic Agents; Benzamides; Blotting, Western; Carbon Isotopes; Cell Line, Tumor; Deoxyglucose; Drug Resistance, Neoplasm; Gas Chromatography-Mass Spectrometry; Glucose; Glucose Transporter Type 1; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Spectroscopy; Piperazines; Protein Transport; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Ribose; RNA, Neoplasm; Time Factors | 2009 |
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species.
Topics: Benzamides; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Deoxyglucose; Enzyme Activation; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Jurkat Cells; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Monosaccharide Transport Proteins; Phloretin; Phosphatidylinositol 3-Kinases; Piperazines; Protein Kinases; Pyrimidines; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Tyrosine; Up-Regulation | 2005 |
Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation.
Topics: Annexin A5; Apoptosis; Benzamides; Biological Transport; Blotting, Western; Cell Survival; Cytokines; Deoxyglucose; Dose-Response Relationship, Drug; Doxycycline; Enzyme Inhibitors; Flow Cytometry; Fusion Proteins, bcr-abl; Glucose; Glucose Transporter Type 1; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Immunohistochemistry; Interleukin-3; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Monosaccharide Transport Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Temperature; Time Factors | 2005 |
Glucose transport regulation by p210 Bcr-Abl in a chronic myeloid leukaemia model.
Topics: Biological Transport; Cell Death; Cell Line; Deoxyglucose; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphatidylinositol 3-Kinases | 2001 |